A Multi-center, Single-arm, Prospective, Non-interventional Study on Vonoprazan in the Real-world Clinical Practice in China
Latest Information Update: 09 Sep 2024
Price :
$35 *
At a glance
- Drugs Vonoprazan (Primary)
- Indications Reflux oesophagitis
- Focus Adverse reactions
- Acronyms VIEW
- Sponsors Takeda
- 26 Oct 2022 Status changed from active, no longer recruiting to completed.
- 24 Oct 2022 Status changed from recruiting to active, no longer recruiting.
- 13 Oct 2022 Planned End Date changed from 29 Sep 2022 to 30 Nov 2022.